Addiction Medicine
FDA/CDC
Two emerging drugs exacerbating opioid crisis
On their own, para-fluorofentanyl and metonitazene can kill the user through respiratory depression, said Dr. Jordan Trecki.
From the Journals
Intranasal oxytocin shows early promise for cocaine dependence
[However], “the findings were paradoxical because there was a greater dropout rate in the intranasal oxytocin group after week 1,” said Dr....
News
If you give a mouse a genetically engineered bitcoin wallet
Plus: Monkeys that don’t drink, water that’s unsafe to drink, and mud that’s unsafe to eat or drink.
From the Journals
Buprenorphine may curb opioid-induced respiratory depression
“I think this is an approach that works, and this study makes that clear,” said Dr. Geert Jan Groeneveld.
Latest News
Doctor’s illegal opioid prescriptions lead to five deaths
The physician often prescribed combinations of medications, such as concurrent opioids, increasing the chances that his patients would become...
From the Journals
Ketamine an ‘intriguing new therapy’ for alcoholism
“Ketamine may support alcohol abstinence by temporarily alleviating depressive symptoms during the relapse period.”
From the Journals
Dramatic increase in driving high after cannabis legislation
“Our findings suggest more [work] is needed to deter this dangerous behavior in light of legalization,” said Dr. Jeffrey Brubacher.
FDA/CDC
Orally dissolving buprenorphine tied to severe tooth decay, FDA warns
Since buprenorphine was approved, the FDA has identified 305 cases of dental problems associated with orally dissolving buprenorphine.
Hard Talk
Should psychiatry categorize
‘substance-induced paraphilia?’
The dopamine receptors of the brain get their fair share amid the didactics we receive in residency. From discussions of antipsychotics and...
From the Journals
Effective alternatives to psychotherapy for borderline personality disorder
At 12 months, there was a mean 28.91-point (23.8%) drop in interpersonal problems, reported lead author Dr. Andrew Chanen.
From the Journals
Study finds sharp drop in opioid scripts among most specialties
A study by the RAND Corp found U.S. clinicians are prescribing fewer opioids, with variation among patients. But the lead author said the report...